The Latest Breaking News from Clinical Trial

A world-first clinical trial involving pet dogs is underway in Perth, and is hoped to uncover a new treatment for children with sarcoma.

In a world first clinical trial, red blood cells that were grown in a laboratory have been transfused into two people.

Shares of oncology-focused biotechnology company Sonnet BioTherapeutics (SONN) have plummeted more than 70% in price year-to-date due to its poor financials and the broad-based market sell-off. However, the company is advancing its drug candidates via research breakthroughs, clinical trials, and strategic initiatives. Given the company’s constant progress, can this biotech…

An Australian-first clinical trial for a new needle-free COVID-19 vaccine has begun on the Sunshine Coast, in good news for those who fear the jab.

Australians living in regional and remote parts of the country could soon have access to specialised health care for diseases such as cancer as a Queensland-led telehealth program expands nationally.

Volunteers receive a transfusion of blood grown in a laboratory from stem cells of donors to see if it lasts longer than blood donated from a standard transfusion.

Those who took a new drug during a clinical trial were found to have significantly lower blood pressure after other traditional medicines had failed.

Researchers said those given it during a clinical trial were found to have significantly lower blood pressure

Scientists say that if proved safe, manufactured blood cells could revolutionise treatments for people with blood disorders

Two successful clinical trials of lab-grown red blood cells could revolutionise treatments for people with rare blood types amid an NHS shortage

Psychedelics biotech company Biomind Labs Inc. (OTC: BMNDF) has announced positive initial results from part 1 of a Phase 2 clinical trial on its proprietary liquid inhaled formulation of DMT, BMND01, designed for Treatment-Resistant Depression (TRD).